Yellow tea polysaccharides protect against non-alcoholic fatty liver disease via regulation of gut microbiota and bile acid metabolism in mice

被引:2
|
作者
Huang, Yuzhe [1 ,2 ,3 ,4 ]
Chen, Hao [1 ,4 ]
Chen, Jielin [1 ,4 ]
Wu, Qingxi [1 ,4 ]
Zhang, Wenna [1 ,4 ]
Li, Daxiang [5 ]
Lu, Yongming [1 ,4 ]
Chen, Yan [1 ,4 ]
机构
[1] Anhui Univ, Sch Life Sci, Hefei 230601, Anhui, Peoples R China
[2] Anhui Univ Chinese Med, Dept Pharm, Hefei 230012, Anhui, Peoples R China
[3] Anhui Acad Chinese Med, Inst Pharmaceut, Hefei 230012, Anhui, Peoples R China
[4] Key Lab Ecol Engn & Biotechnol Anhui Prov, Hefei 230601, Peoples R China
[5] Anhui Agr Univ, Sch Tea & Food Sci, State Key Lab Tea Plant Biol & Utilizat, Hefei 230036, Anhui, Peoples R China
关键词
Yellow tea; Polysaccharies; NAFLD; Targeted metabolomics; Gut microbiota; RECEPTOR;
D O I
10.1016/j.phymed.2024.155919
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Background: Nonalcoholic fatty liver disease (NAFLD) is a major clinical and global public health issue, with no specific pharmacological treatment available. Currently, there is a lack of approved drugs for the clinical treatment of NAFLD. Large-leaf yellow tea polysaccharides (YTP) is a natural biomacromolecule with excellent prebiotic properties and significant therapeutic effects on multiple metabolic diseases. However, the specific mechanisms by which YTP regulates NAFLD remain unclear. Purpose: This study aims to explore the prebiotic effects of YTP and the potential mechanisms by which it inhibits hepatic cholesterol accumulation in NAFLD mice. Methods: The effects of YTP on lipid accumulation were evaluated in NAFLD mice through obesity trait analysis and bile acids (BAs) metabolism assessment. Additionally, fecal microbiota transplantation (FMT) was performed, and high-throughput sequencing was employed to investigate the mechanisms underlying YTP's regulatory effects on gut microbiota and BA metabolism. Results: Our study demonstrated that YTP altered the constitution of colonic BA, particularly increasing the levels of conjugated BA and non-12OH BA, which suppressed ileum FXR receptors and hepatic BA reabsorption, facilitated BA synthesis, and fecal BA excretion. The modifications were characterized by a decrease in the levels of FXR, FGF15, FGFR4, and ASBT proteins, and an increase in the levels of Cyp7a1 and Cyp27a1 proteins. YTP might affect enterohepatic circulation and by the activated the hepatic FXR-SHP pathway. Meanwhile, YTP reshaped the intestinal microbiome structure by decreasing BSH-producing genera and increasing taurine metabolism genera. The correlation analysis implied that Muribaculaceae, Pseudomonas, acterium_coprostanoligenes_group, Clostridiales, Lachnospiraceae_NK4A136_group, Delftia, Dubosiella, and Romboutsia were strongly correlated with specific BA monomers. Conclusions: YTP modulates bile salt hydrolase-related microbial genera to activate alternative bile acid synthesis pathways, thereby inhibiting NAFLD progression. These results suggest that YTP may serve as a potential pro- biotic formulation, offering a feasible dietary intervention for NAFLD.
引用
收藏
页数:17
相关论文
共 50 条
  • [41] Diet, Gut Microbiota and Non-Alcoholic Fatty Liver Disease: Three Parts of the Same Axis
    Quesada-Vazquez, Sergio
    Aragones, Gerard
    Del Bas, Josep M.
    Escote, Xavier
    CELLS, 2020, 9 (01)
  • [42] A consortium of Hordeum vulgare and gut microbiota against non-alcoholic fatty liver disease via data-driven analysis
    Lee, Su-Been
    Gupta, Haripriya
    Min, Byeong-Hyun
    Ganesan, Raja
    Sharma, Satya Priya
    Won, Sung-Min
    Jeong, Jin-Ju
    Cha, Min-Gi
    Kwon, Goo-Hyun
    Jeong, Min-Kyo
    Hyun, Ji-Ye
    Eom, Jung-A
    Park, Hee-Jin
    Yoon, Sang-Jun
    Lee, Sang Youn
    Choi, Mi-Ran
    Kim, Dong Joon
    Oh, Ki-Kwang
    Suk, Ki-Tae
    ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2024, 52 (01) : 250 - 260
  • [43] Polysaccharide from Panax japonicus CA Mey prevents non-alcoholic fatty liver disease development based on regulating liver metabolism and gut microbiota in mice
    Wu, Yi
    Yin, Wen
    Hao, Ping
    Chen, Yueru
    Yu, Lingyun
    Yu, Xingjian
    Wu, Yu
    Li, Xiaocong
    Wang, Wenjia
    Zhou, Hui
    Yuan, Yuan
    Quan, Xiaoyu
    Yu, Yue
    Hu, Bing
    Chen, Shouhai
    Zhou, Zhenlei
    Sun, Wenjing
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 260
  • [44] Amelioratory Effect of Resistant Starch on Non-alcoholic Fatty Liver Disease via the Gut-Liver Axis
    Zhu, Weifeng
    Zhou, Ying
    Tsao, Rong
    Dong, Huanhuan
    Zhang, Hua
    FRONTIERS IN NUTRITION, 2022, 9
  • [45] Gut Microbiota and Bile Acid Metabolism in the Mechanism of Ginsenoside Re Against Nonalcoholic Fatty Liver Disease
    Zheng, Yanfang
    Chen, Jiaying
    Zhang, Ying
    Guan, Huaying
    Deng, Shan
    Chang, Dennis
    Wang, Yitao
    Lu, Jinjian
    Zhou, Xian
    Xie, Qin
    Song, Jianyuan
    Huang, Mingqing
    PHYTOTHERAPY RESEARCH, 2025,
  • [46] Tauroursodeoxycholic Acid Improves Nonalcoholic Fatty Liver Disease by Regulating Gut Microbiota and Bile Acid Metabolism
    Wang, Huan
    Guo, Yi
    Han, Weiting
    Liang, Meng
    Xiao, Xiao
    Jiang, Xiaowen
    Yu, Wenhui
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2024, 72 (36) : 20194 - 20210
  • [47] Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice
    Le Roy, Tiphaine
    Llopis, Marta
    Lepage, Patricia
    Bruneau, Aurelia
    Rabot, Sylvie
    Bevilacqua, Claudia
    Martin, Patrice
    Philippe, Catherine
    Walker, Francine
    Bado, Andre
    Perlemuter, Gabriel
    Cassard-Doulcier, Anne-Marie
    Gerard, Philippe
    GUT, 2013, 62 (12) : 1787 - 1794
  • [48] Gut Dysfunction and Non-alcoholic Fatty Liver Disease
    Grabherr, Felix
    Grander, Christoph
    Effenberger, Maria
    Adolph, Timon Erik
    Tilg, Herbert
    FRONTIERS IN ENDOCRINOLOGY, 2019, 10
  • [49] Gut Microbiome-Mediated Alteration of Immunity, Inflammation, and Metabolism Involved in the Regulation of Non-alcoholic Fatty Liver Disease
    He, Li-Hong
    Yao, Dun-Han
    Wang, Ling-Yun
    Zhang, Lei
    Bai, Xue-Li
    FRONTIERS IN MICROBIOLOGY, 2021, 12
  • [50] Effects of Tea against Alcoholic Fatty Liver Disease by Modulating Gut Microbiota in Chronic Alcohol-Exposed Mice
    Li, Bangyan
    Mao, Qianqian
    Zhou, Dandan
    Luo, Min
    Gan, Renyou
    Li, Hangyu
    Huang, Siyu
    Saimaiti, Adila
    Shang, Ao
    Li, Huabin
    FOODS, 2021, 10 (06)